Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

ACIP Live Meeting Archive - June 2017

August 3, 2017: Content on this page kept for historical reasons.

 

 

Videos: June 21-22, 2017

Meeting June 21-22 [2 pages]

Video of ACIP meetings is now posted to the CDC Streaming Health channel* on YouTube. View the specific ACIP channel on YouTube or view specific links below. Controls for video volume, pause, and rewind appear along the bottom of the display.

 

June 21, 2017 (Day 1)

Welcome – Introductions [13 minutes]
Welcome & Introductions

Herpes Zoster Vaccines [60 minutes]
Zostavax Phase IV study; Zostavax GRADE; Herpes Zoster vaccine revaccination data

Herpes Zoster ; Varicella; Anthrax Vaccine Workgroup; Vaccine supply [105 minutes]
HCost effectiveness models ,Considerations for the use of herpes zoster vaccines, Impact of the U.S. varicella vaccination program on the epidemiology of herpes zoster, Anthrax vaccine workgroup information, vaccine supply and public comments

Influenza [123 minutes]
Influenza surveillance update, Vaccine effectiveness update, Vaccine safety update, Flublok in pregnancy, Public comment, Proposed recommendations

Hepatitis Vaccines [121 minutes]
Hepatitis A vaccine background, Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children, Updated ACIP routine recommendations for use of hepatitis A vaccine, Updated ACIP recommendations for use of hepatitis A vaccine and immune globulin for post-exposure prophylaxis and for international travelers

 

Top of Page

June 22, 2017 (Day 2)

Agency Updates;Dengue Virus Vaccines, Yellow Fever Vaccine [74 minutes]
Agency updates & unfinished business, Dengue epidemiology in United States and U.S. territories; Update on implementation of IND protocol and yellow fever vaccine distribution, Review of protocol inclusion criteria and current ACIP recommendations

Mumps ; Meningococcal, VAERS, Evidence Based recommendations [136 minutes]
Update on mumps epidemiology in the United States, 2017 and review of published studies of 3rd dose MMR for mumps outbreak control Effectiveness of a third MMR dose during a mumps outbreak in a highly vaccinated university population, 2015-2016; Meningococcal disease and vaccine response in patients receiving Eculizumab; Vaccine Adverse Event Reporting System (VAERS); Vaccine safety: transition to the new VAERS 2.0 reporting form

*The CDC Streaming Health channel on YouTube hosts more than 600 videos on a variety of health topics. YouTube’s design allows viewing on mobile devices, tablets, desktops, and laptops.

Top of Page

TOP